Toggle Nav
Close
  • Menu
  • Setting

Burfiralimab

Catalog No.
BA2307
Burfiralimab (hzVSF-v13) is a monoclonal antibody directed against waveform proteins expressed on the surface of virus-infected cells with broad-spectrum antiviral activity and anti-inflammatory effects against virus-induced inflammation.
Grouped product items
SizePriceStock Qty
1mg
$216.00
Ship with 10-15 days
5mg
$540.00
Ship with 10-15 days
For scientific research use only and should not be used for diagnostic or medical purposes.

Tel: +1-832-696-8203

Email: [email protected]

Worldwide Distributors

Background

Burfiralimab (hzVSF-v13) is a monoclonal antibody directed against waveform proteins expressed on the surface of virus-infected cells with broad-spectrum antiviral activity and anti-inflammatory effects against virus-induced inflammation.Burfiralimab is available for use in the Critical Illness COVID-19 study.

Chemical Properties

Physical AppearanceA liquid
Storage-20°C
Cas No.2460809-80-5
SynonymshzVSF-v13
Shipping ConditionSmall Molecules with Blue Ice, Modified Nucleotides with Dry Ice.
General tips We do not recommend long-term storage for the solution, please use it up soon.